5-108380887-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000542267.7(FBXL17):c.805G>T(p.Gly269Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000726 in 1,239,110 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000542267.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL17 | NM_001163315.3 | c.805G>T | p.Gly269Cys | missense_variant | 1/9 | ENST00000542267.7 | NP_001156787.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL17 | ENST00000542267.7 | c.805G>T | p.Gly269Cys | missense_variant | 1/9 | 1 | NM_001163315.3 | ENSP00000437464 | P1 | |
FBXL17 | ENST00000518486.1 | n.77G>T | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151852Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000368 AC: 4AN: 1087150Hom.: 0 Cov.: 32 AF XY: 0.00000390 AC XY: 2AN XY: 513402
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151960Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74244
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.805G>T (p.G269C) alteration is located in exon 1 (coding exon 1) of the FBXL17 gene. This alteration results from a G to T substitution at nucleotide position 805, causing the glycine (G) at amino acid position 269 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at